Silo Pharma, Inc. (SILO) vs Alaunos Therapeutics, Inc. (TCRT)

A side-by-side comparison of Silo Pharma, Inc. and Alaunos Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — SILO vs TCRT

growth of $100 · dividends reinvested · last 6y
SILO -99.4% (-57.8%/yr)TCRT -99.8% (-65.5%/yr)SILO compounded faster over this window
050100150Start $10020222023202420252026$1$0
SILO TCRT

SILO vs TCRT: by the numbers

  • •TCRT is the larger company ($2M vs $2M market cap).
  • •Both run net losses; SILO's is the smaller (-8269.53% vs -133666.67% net margin).

Metrics side by side

Valuation

MetricSILOTCRT
P/S ratio29.95595.80
P/B ratio0.332.74

Profitability

MetricSILOTCRT
Gross margin-1128.89%-27160.00%
Operating margin-5936.95%-84500.00%
Net margin-8269.53%-133666.67%
ROE-91.52%-615.03%
ROIC-91.31%-622.39%

Growth (annualized)

MetricSILOTCRT
Revenue CAGR (5Y)0.29%N/A
Total return CAGR (5Y)-61.41%-69.13%

Frequently asked

How have SILO and TCRT total returns compared?
Over the past 5 years, SILO delivered -61.41% and TCRT delivered -69.13% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.